Keep up to speed with the latest advances in Controlled-Release

Overcome Formulation challenges for oral delivery of peptide and lipid-based therapeutics
Spread the Word
Listed Under

* Formulation
* Extended Release
* Drug Delivery
* Parenteral Drug Delivery
* Transdermal Drug Delivery

* Pharmaceuticals

* England

Jan. 20, 2012 - PRLog -- Examining the latest developments in nanomedicine, join SMi’s ninth annual Controlled-Release conference, featuring fresh presentations from leading companies in this interesting field.  Topics include enhancing in vivo circulation time, extending dissolution kinetics, and improving delivery with drug-porous nanocarriers, lipid-based compounds and biologics.  Whether your interests lie in formulation, particle design or drug delivery book now to secure your place!  

6 Key reasons why you should attend this interesting event include:

•    Increasing patent revenue for oral and non oral drug delivery products
•    Extending product lifecycles through reformulation to keep market share
•    Accelerating to phase III faster with lipid-based compounds
•    Improving manufacturing efficiency and scale-ability for miniaturisation and bead milling
•    Reducing costs with in silico applications to maximise commercial development
•    Implementing lessons for ADMET testing when using nanoparticles

There will also be two interactive pre-conference workshops held on the 27th March 2012 on.....

A.   Accelerating first-in-human studies (FIH) with lipid-based formulations
Hosted by: David J. Hauss, Principal, Hauss Associates
Hassan Benameur, Senior Director Pharmaceutical Sciences, Capsugel
Senior Representative, Gattefossé

B.    A trip through the life and work of a patent
Hosted by: Jonathan Couchman, Partner, Harrison Goddard Foote (HGF) and Martyn Fish, Partner, HGF Law

For more information and to book your place visit

Alternatively, contact Ninica Hussain at Tel: +44 (0)20 7827 6115 or Email:
Source:SMi Group
Email:*** Email Verified
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Daily News
Weekly News

Like PRLog?
Click to Share